Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"They did seem to do OK in India Phase I trial. "
Is there some regulatory reporting that confirms that? I probably couldn't follow it but I'd like to know if it exists.
(I see the "seem" in there.)
Good point. Yes, I purchased 100 of IPIX @ $.0158 to test Schwab's treatment of Expert Market trading. I continue to hold them and I ain't dead yet so I guess I'm not a true investor.
As is true for many other IPIX investors I have lost most of my investment. In my case that was $8.54, including the $6.95 commission charged for an OTC trade.
Did you fare as well when you escaped NNVC as Ehrlich did when he escaped it?
Do you sense a pattern? From your last post to that board in 2019: "Shoulda sold most at $7 like many did."
ps. I've given you my buy info here. Care to share yours?
Of course you don't. How about giving a couple good reasons to hold IPIX instead? Or a target sell price!
Only Aruda knows.
He ceased to be a 5% holder in 2018 and as a result was no longer obligated to file.
"trashing a trash stock?"
I've been revealing the truth about this Company's flaws for quite some time and there are still a few who refuse to listen.
There is no such thing as a trash stock but there are plenty of trash companies. There's nothing wrong with trashing a trash company, is there? Isn't the truth in everybody's interest?
I don't need or care to know who you are. You said that you're a true investor and this was my response to that:
A true investor wouldn't be caught dead holding this crap.
"however I am a true investor"
A true investor wouldn't be caught dead holding this crap.
"I'm good either way...I'm not here 24/7 and not at all obsessed. This is just entertainment for me....if I make money, great, If I lose, its a tax write off......."
He didn't make it up. YOU SAID IT.
Trading of Ipix action sleeps until the Company catches up on its public information requirements, another one of which came due last week (a 10-Q for the quarter ended 3/31).
I'm sure you understand how the Expert Market works.
IPIX trading isn't dormant for the usual reason....no productive operations....it's dormant due to a failure to provide required information.
Both reasons can be attributed to Leo Ehrlich. Where is he?
And there's the dump.
I wouldn't know how to go about it.
There's nothing stopping a distributor from putting a product in a catalog without actually stocking it.
Any shipments of brilacidin to a distributor for resale would have to have been treated as revenue in the financials.
Can you explain why IPIX has never recorded a single dollar of revenue from the sale of brilacidin that you say that you own?
A BSE/TSE statement is requested by countries to prevent imports that could potentially contain ingredients associated with Bovine Spongiform Encephalopathy (BSE) or other transmissible spongiform encephalopathies (TSEs)12. BSE is a degenerative neurological disease affecting cattle2.
It's an assurance that the product that Biosynth is distributing is not being manufactured in the presence of mad cow or related disease.
"Regeneron worked for 18 years to find a first partner."
How many years was it before their CEO ran away and hid from investors, failing to provide any public information?
(Actually he's still there....been there since 1988.)
No more Regeneron stories, please. The one single point of comparison is a lack of success in the early years. Nothing else.
Were the Directors foolish to resign? Will CEO Leo Ehrlich ever be heard from again?
Will these be the last words the public ever hears from this Company?
Looks like a mini pump and dump.
And the sensible reason anyone would do that professor?
There isn't one. Just as there is no sensible reason to hold IPIX shares at this point.
Some goober (probably goobers) discovered that you can add to the board view count by just refreshing the page. And you don't even have to be a board member to do it.
Even funnier is that you find that statistic meaningful.
There's no mention of it on the docket.
I don't know what "Review Appeals Filed" means.
When the item first appeared on the docket in April it said:
"Review Appeals Filed 03/11/2024 05/08/2024"
I believe that that was the basis for olden_grumpini's comment
Now it says:
"Review Appeals Filed 03/11/2024 06/12/2024"
IPIX filed a Notice of Appeal on 3/7 but that's just a statement of intent. An actual Appeal is a comprehensive filing providing a detailed basis.
I think.
o_g? Any thoughts?
"Sure is a lot of views for a "dead company". 😁
How can this be?"
It's nonsense, obviously.
Have you appealed to your broker Fidelity based on "accredited investor" status?
"The SEC defines an accredited investor as someone who meets one of the following three requirements:
Has an individual income of more than $200,000 per year, or a joint income of $300,000, in each of the last two years and expects to reasonably maintain the same level of income.
Has a net worth exceeding $1 million, either individually or jointly with his or her spouse.
Is a general partner, executive officer, director or a related combination thereof for the issuer of a security being offered."
https://www.bing.com/search?form=MOZLBR&pc=MOZR&q=%22accredited+investor%22+definition
Still trying to help in spite of your occasional insult. I figure if anyone deserves to own more shares of IPIX it's you.
Next come the Herpes, Human Papillomavirus (HPV), HIV, Hendra and Nipah Viruses, Ebola, Marburg and sniffles PRs....and who can forget dengue!
Wonder if they'll raise that good old drug design in the field capability?
Uncle Miltie must be bummed that he's missing out.
per Schwab:
""Starting on May 28, 2024, the settlement period for most securities traded on U.S. exchanges or over the counter will shorten from two business days (T+2) to one business day (T+1)."
Without any trading that's not gonna matter much.
Are these investors still here?
"At one point one of the biggest knocks on NNVC was that "they would never be able to scale up production" sufficiently. They appear to have gotten over that hump now."
Is there something in particular that makes it appear that way to you?
"For a security to become worthless, it not only needs to have no value, but it needs to have no potential to regain value."
That's a fine theory regarding value but if you hope to recognize value in the price of the stock you need buyers and even those who are willing to buy have been met at the door of their brokerages by a sign saying "no buy orders accepted".
How do you propose that the Company will overcome that problem?
It was 100% correct when it was written. This message, which appears in the IPIX trading session now when a buy order is attempted, did NOT appear when I said they would take your order:
Hey! Long time no see. Your last appearance had you asking "Is trading halted?" on a day that 125million shares were traded. People with IPIX shares at the close of trading that day held them at $.0892, about 42 times what they go for today.
Don't be such a stranger!
"Thank you for this Schwab information. If it is true and I can buy I will make a new account."
Did you find it to be true? (I don't care if you made a new account.)
And what happened to this?
Nothing.
I don't have either notation but they look like footnotes. Are 3 and 4 described further down the page?
What page are you looking at? My Schwab account doesn't have that notation on the Position page....phone or computer.
ABSSSI - In February 2016, the Company submitted a Special Protocol Assessment (SPA) request, along with a final protocol, to the FDA, for a Phase 3 clinical trial of Brilacidin for the treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). We received from the FDA comments and considerations for incorporation into our study design. Management decided to delay its response to the FDA due to the low price per share of our common stock and the many multiple million dollar costs associated with a Phase 3 program. Our strategy, for now, is to achieve success with other trials and attract partnering opportunities that may provide significant upfront payments and milestone payments, which can then be used to fund the ABSSSI program. We see ABSSSI as the appropriate gateway indication in infectious diseases, enabling potential further studies of Brilacidin’s use for implant coating and biofilm infections.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm (2023 10-K)
Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting.
https://www.otcmarkets.com/stock/IPIX/overview (today)
The same results could have been achieved if the candidate tested was corn flakes.
Go to the original article.
There are two tables labeled Table 1 Brilacidin activity against problem pathogens and Table 2 Initial screen of Brilacidin activity against other problem pathogens. All you need to see them is click on the boxes with the arrows.
I haven't studied them too closely but those SEEM to be the only things that you missed. They make themselves apparent when you click the download button, as suggested.
It is free, but you only posted part of the article. Press the Download button.
"Has anyone popped the $26 or so bucks for a copy of the article?"
Why do that when you can download it from the linked page?
Bullshit. Never happened.
No need to guess:
"Brilacidin (N4, N6-bis(3-(5-gaunidinopentanamido)-2-(R)-pyrrolidin-3-yl)oxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide tetrahydrochloride) (C40H50F6N14O6.4HCl), MW 1082.7, sterile and >98% pure, was supplied by Innovation Pharmaceuticals, Wakefield, MA, USA. It was supplied as a solid and was readily soluble in water and liquid media, such as RPMI-1640. To convert µg/mL, as expressed in this paper, to millimolar, multiply µg/mL by 0.924. "
Would they call that "funding"?
You're wrong about this. Learn the difference between IHub administrators and Board moderators....it's significant.
I did the following, using 3M shares @$.002, before I said that Schwab might be able to help...I had no reason to mislead you:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174252754
Obviously I cancelled the trade before it executed. One issue you might run into is their policy regarding the taking of a NEW IPIX position with them. I have 100 shares in one of my accounts so the 3M order would not have been a new position. Different brokers handle Expert Market orders differently and I've heard that some won't take a NEW position.
You might want to call before applying for a new account in case they aren't taking new opening orders.